ER Bcl-2在宫颈病变发生中的相关性研究

陈艳霞 马彩玲 朱红艳

陈艳霞, 马彩玲, 朱红艳. ER Bcl-2在宫颈病变发生中的相关性研究[J]. 中国肿瘤临床, 2013, 40(23): 1427-1430. doi: 10.3969/j.issn.1000-8179.20130774
引用本文: 陈艳霞, 马彩玲, 朱红艳. ER Bcl-2在宫颈病变发生中的相关性研究[J]. 中国肿瘤临床, 2013, 40(23): 1427-1430. doi: 10.3969/j.issn.1000-8179.20130774
Yanxia CHEN, Cailing MA, Hongyan ZHU. Correlation of ER with Bcl-2 in cervical cancer and pre-cancerous lesion[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(23): 1427-1430. doi: 10.3969/j.issn.1000-8179.20130774
Citation: Yanxia CHEN, Cailing MA, Hongyan ZHU. Correlation of ER with Bcl-2 in cervical cancer and pre-cancerous lesion[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(23): 1427-1430. doi: 10.3969/j.issn.1000-8179.20130774

ER Bcl-2在宫颈病变发生中的相关性研究

doi: 10.3969/j.issn.1000-8179.20130774
基金项目: 

新疆医科大学第一附属医院妇科 2011211A070

详细信息
    通讯作者:

    马彩玲  hymcl@sina.com

Correlation of ER with Bcl-2 in cervical cancer and pre-cancerous lesion

Funds: 

the Natural Science Foundation of Xinjiang Autonomous Region 2011211A070

More Information
  • 摘要:   目的  探讨ER、Bcl-2蛋白在不同程度宫颈病变中的相关性及意义。  方法  免疫组织化学检测慢性宫颈炎20例、低度宫颈上皮内瘤变30例、高度宫颈上皮内瘤变70例及80例宫颈癌组织中ER和Bcl-2蛋白的表达。  结果  ER在慢性宫颈炎组中阳性率为75%,随着宫颈病变程度的加重,其表达率逐渐降低(χ2=24.266,P < 0.01),与慢性宫颈炎组比较,CINⅡ~Ⅲ组和宫颈鳞癌组差异有统计学意义,CINⅠ组差异无统计学意义(χ2=0.751,P=0.386)。与肿瘤组织类型及病理分级无关;BCL-2在宫颈鳞癌组中阳性率为75.38%,随着宫颈病变程度的加重,其表达率逐渐增高(χ2=27.715,P < 0.01),与慢性宫颈炎组比较,CINⅠ组、CINⅡ~ Ⅲ组及宫颈鳞癌组差异均有统计学意义。与宫颈鳞癌病理分级相关(χ2=4.862,P=0.027),与肿瘤组织类型无关(P=0.500);CIN Ⅱ~Ⅲ组中联合表达阳性率为38.57%(27/70),宫颈鳞癌组中联合表达阳性率为15.38%(10/65),差异具有统计学意义(χ2=9.108,P=0.003)。CINⅡ~Ⅲ组中ER与Bcl-2蛋白表达存在相关(r=0.506,P < 0.01),其余组中无相关关系。  结论  在宫颈病变的进展中,ER和Bcl-2表达呈相反趋势,在CINⅡ~Ⅲ组中有相关性,联合表达阳性可能是宫颈高度上皮内瘤变发生的主要机制之一。

     

  • 图  1  ER和Bcl-2蛋白在不同宫颈病变组织中的表达(ISH×200)

    A-F:ER expression in different degrees of cervical lesions. A:Normal cervical tissue;B:CINⅠ;C:CINⅢ;D:Carcinoma in situ with glandular involvement;E:squamous cell carcinoma of uterine cervix;F:Adenocarcinoma of cervix;J:normal cervical tissue;H:Bcl-2 expression in squamous cell carcinoma of uterine cervix

    Figure  1.  ER and Bcl-2 expressions in different degrees of cervical lesions(ISH×200)

    表  1  ER和Bcl-2在不同宫颈病变组织中的表达

    Table  1.   ER and Bcl-2 expression among different degrees of cervical lesions

    表  2  ER和Bcl-2在不同类型宫颈癌组织中的表达

    Table  2.   ER and Bcl-2 expression among different degrees of cervical cancer lesions

    表  3  ER与Bcl-2在不同宫颈病变组织中阳性表达的相关比较

    Table  3.   Comparison of ER and Bcl-2 expression among different degrees of cervical lesions

  • [1] Gariglio P, Gutiérrez J, Cortés E, et al. The role of retinoid deficiency and estrogens as cofactors in cervical cancer[J]. Arch Med Res, 2009, 40(6): 449-465. doi: 10.1016/j.arcmed.2009.08.002
    [2] Chung SH, Franceschi S, Lambert PF. Estrogen and ERalpha: culprits in cervical cancer[J]? Trends Endocrinol Metab, 2010, 21(8): 504-511. doi: 10.1016/j.tem.2010.03.005
    [3] Thaler S, Schmidt M, Schad A, et al. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development[J]. Oncogene, 2012, 31(47): 4912-4922. doi: 10.1038/onc.2011.658
    [4] Yu X, Zhang X, Dhakal IB, et al. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells[J]. BMC Cancer, 2012, 12(29): 1471-2407.
    [5] Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia[J]. N Eng J Med, 2009, 361(3): 271-278. doi: 10.1056/NEJMct0806938
    [6] zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application[J]. Nat Rev Cancer, 2002, 2(5): 342-350. doi: 10.1038/nrc798
    [7] Alsbeih G, Al-Harbi N, El-Sebaie M, et al. HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia[J]. Infect Agent Cancer, 2013, 8(1): 15. doi: 10.1186/1750-9378-8-15
    [8] Shai A, Pitot HC, Lambert PF. p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers [J]. Cancer Res, 2008, 68(8): 2622-2631. doi: 10.1158/0008-5472.CAN-07-5266
    [9] Rinaldi S, Plummer M, Biessy C, et al. Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study[J]. Cancer Epidemiol Biomarkers Prev, 2011, 20(12): 2532-2540. doi: 10.1158/1055-9965.EPI-11-0753
    [10] 王金桃, 高尔生, 丁玲, 等. 内源性雌孕激素及其受体与宫颈癌的关系[J]. 中华肿瘤, 2006, 28(7): 494-497. doi: 10.3760/j.issn:0253-3766.2006.07.004
    [11] Zhai Y, Bommer GT, Feng Y, et al. Loss of Estrogen Receptor 1 Enhances Cervical Cancer Invasion[J]. Am J Pathol, 2010, 177(2): 884-895. doi: 10.2353/ajpath.2010.091166
    [12] Elson DA, Riley RR, Lacey A, et al. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis[J]. Cancer Res, 2000, 60(5): 1267-1275.
    [13] 赵富玺, 穆雅琴, 郭俊成, 等. Bcl-2 Survivin CD44v6的表达HPV16/ 18感染及其与宫颈癌发生的相关性探讨[J]. 中国肿瘤临床, 2007, 34 (8): 426-429. doi: 10.3969/j.issn.1000-8179.2007.08.002
    [14] Dolmetsch RE, Pajvani U, Fife K, et al. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway[J]. Science, 2001, 294 (5541): 333-339. doi: 10.1126/science.1063395
    [15] Dremina ES, Sharov VS, Schöneich C. Heat-shock proteins attenuate SERCA inactivation by the anti-apoptotic protein Bcl-2: possible implications for the ER Ca2+-mediated apoptosis[J]. Biochem J, 2012, 444(1): 127-139. doi: 10.1042/BJ20111114
  • 加载中
图(1) / 表(3)
计量
  • 文章访问数:  63
  • HTML全文浏览量:  24
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-05-18
  • 修回日期:  2013-07-15

目录

    /

    返回文章
    返回